KORU Medical Systems, Inc. (NASDAQ:KRMD)
| Market Cap | 136.19M-28.9% |
| Revenue (ttm) | 45.11M+22.4% |
| Net Income | -1.82M+59.7% |
| EPS | -0.04+61.6% |
| Shares Out | 45.93M |
| PE Ratio | n/a |
| Forward PE | 143.58 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 13,678.078 |
| Open | 2.95 |
| Previous Close | 2.98 |
| Day's Range | 2.95 - 2.99 |
| 52-Week Range | 2.86 - 6.61 |
| Beta | 0.39 |
| Analysts | Buy |
| Price Target | 6.00(+102.36%) |
| Earnings Date | Nov 11, 2026 |
KORU Medical Systems, Inc. has a live Insider Score.
Scored on 1 qualifying trade from 1 insider in the last 90 days.
About KRMD
KORU Medical Systems, Inc. is dedicated to the development, manufacturing, and commercialization of mobile medical devices, primarily serving the ambulatory infusion market across both the United States and international territories. The company's primary offerings revolve around mechanical infusion solutions, notably their FREEDOM infusion systems. These comprehensive systems encompass components such as the FREEDOM60 and FreedomEdge syringe drivers, alongside specialized HIgH-Flo subcutaneous safety needle sets and precision flow rate tubing. Beyond their product range, KORU Medical also supplies educational content and training materials to healthcare professionals, patients, and patient advocates. The distribution of their products is managed through a combination of direct sales efforts, partnerships with medical device distributors, and online channels. Established in 1980, the firm's corporate headquarters are situated in Chester, New York.
What Are Insiders Doing?
View the trades behind this meter — each links to its SEC Form 4 →
Open-market Form 4 purchases (code P) vs sales (code S) on file for this company. Grants, option exercises and tax withholdings are excluded. Informational only.
$KRMD stock is featured in our Insider Score Rankings, and Insider Trades datasets.
→ All Stock ListsRecently reported changes in KRMD holdings by institutional investors
Latest 0 13F filings · Source: SEC EDGAR
View all institutional owners →Insider Trading
Quarterly net insider trading by KRMD's directors and management
Source: SEC EDGAR (Form 4)
Corporate Lobbying
KRMD Estimated quarterly lobbying spending
Source: U.S. Senate LDA
KRMD Revenue by Segment or Geography
As of: Q2 2026 (Jun 30, 2026) · Source: SEC EDGAR (10-Q)
U.S. Patents
New KRMD patent grants
Source: USPTO Open Data Portal
Government Contracts
Estimated quarterly amount awarded to KRMD from public contracts
Source: USAspending.gov
Top ETF Holders
ETFs with the largest estimated holdings in KRMD
| ETF | Est. Holding Size |
|---|---|
| VTIVanguard Morningstar Total Stock Market ETF | $4.14M |
| IWMiShares Russell 2000 ETF | $3.46M |
| VXFVanguard Extended Market ETF | $1.72M |
| IWOiShares Russell 2000 Growth ETF | $1.27M |
| VTWOVanguard Russell 2000 ETF | $852.57K |
| IWCiShares Micro-Cap ETF | $407.47K |
Estimated from each fund’s disclosed top holdings × AUM
KRMD Insider Score
Our composite score: insider buying, sector, volume, tone & dilution
Bull Case vs Bear Case
AI-generated from KRMD’s recent data — informational, not investment advice
Insider Score
Our 0–100 Insider Score and the signals behind it.
The live Insider Score and its full factor breakdown are included with Insider Access.
Unlock Insider Score